An unusual presentation of neurosarcoidosis in an 11-year-old boy

Canadian Journal of Neurological Sciences

Volumn 36, Issue 6, 2009, Pages 783-786

  Scholten, V ^a   Ten Hove, W M ^b   MacDonald, E A ^a,c  

^a Department of Pediatrics ^*

^b QUEEN S UNIVERSITY   (Canada)

^c HOTEL DIEU HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETANERCEPT; HYDROXYCHLOROQUINE; INFLIXIMAB; LORAZEPAM; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHENYTOIN; PROPRANOLOL; STEROID; TACROLIMUS; THALIDOMIDE; TUMOR NECROSIS FACTOR INHIBITOR;

ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONJUNCTIVAL BIOPSY; DIPLOPIA; DISEASE COURSE; DISEASE EXACERBATION; EPILEPTIC STATE; EYE DISCHARGE; EYE DISEASE; FRONTAL LOBE; HEADACHE; HUMAN; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PTOSIS; RECOMMENDED DRUG DOSE; SARCOIDOSIS; SCHOOL CHILD; SEIZURE; STEROID THERAPY; WHITE MATTER;

EID: 70350292638     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100008453     Document Type: Article

References (19)

1. Kone-Paut I, Portas M, Wechssler B, Girard N, Raybaud C. The pitfall of silent neurosarcoidosis. Pediatr Neurol. 1999;20:215-218
2. Zajicek JP, Scolding NJ, Foster O, Rovaris M, Evanson J, Moseley IF, et al. Central nervous system sarcoidosis-diagnosis and management. Q J Med. 1999;92:103-117
3. Hoitsma E, Faber CG, Drent M, Sharma OP. Neurosarcoidosis: A clinical dilemma. Lancet Neurol. 2004;3(7):397-407.
4. Gullapalli D, Phillips LH II. Neurological manifestations of sarcoidosis. Neurol Clin. 2002;20:59-83.
5. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med. 1997;336:1224-1234
6. Bauman RJ, RobertsonWC Jr. Neurosarcoid presents differently in children than in adults. Pediatrics. 2003;112:e480-6.
7. Hahn JS, Pohl D, Rensel M, Rao S. Differential diagnosis and evaluation in pediatric multiple sclerosis. Neurol. 1997;68(16): S13-22.
8. McAdam LC, Blaser SI, Banwell BL. Pediatric tumefactive demyelination: case series and review of the literature. Pediatr Neurol. 2002;26:18-25.
9. Ghassemi R, Antel SB, Naravan S, Franci SJ, Bar-Or A, Sadovnick AD, et al. Canadian pediatric demyelinating disease. Lesion distribution in children with clinically isolated syndromes. Ann Neurol. 2008 Mar;63(3):401-405
10. Nowak DA, Widenka DC. Neurosarcoidosis: A review of its intracranial manifestations. J Neurol. 2001;248:363-372
11. Aksamit A. Continuum, neurologic manifestations of systemic disease. AAN. Feb 2008;14(1):181-196
12. Spencer TS, Campellone JV, Maldonado I, Huang N, Usmani Q, Reginato AJ. Clinical and magnetic resonance imaging manifestations of neurosarcoidosis. Semin Arthritis Rheum. 2005;34(4):649-661
13. Stern BJ. Neurological complications of sarcoidosis. Curr Opin Neurol. 2005;17(3):311-316
14. Given CA, Stevens BS, Lee, C. The MRI appearance of tumefactive demyelinating lesions. AJR Am J Roentgenol. 2004;182(1): 195-199
15. Pittock S, Lennon V, Krecke K, Wingerchuk D, Lucchinetti C, Weinshenker B. Brain abnormalities in neuromyelitis optica. Arch Neurol. 2006;63(3):390-396
16. Barkovich JA. Intracranial, orbital, and neck masses of childhood. In: Pediatric Neuroimaging. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 513.
17. Banwell B, Shroff M, Ness JM, Jefery D, Schwid S, Weinstock-Guttman G. International Pediatric MS Study Group. MRI features of pediatric multiple sclerosis. Neurology. 2007;17;68 (16 Suppl 2):S46-53.
18. Puri V, Chaudhry N, Gulati P, Tatke M, Singh D. Recurrent demyelination in a child. J Clin Neurosci. 2005;12(4):495-500.
19. Lower EE, Broderick JP, Brott TG, Baughman RP. Diagnosis and management of neurological neurosarcoidosis. Arch Intern Med. 1997;157(16):1864-1868